Biolegend Inc. Reagents and Kits for the Critical Care Medicine Department (CCMD)

Title Biolegend Inc. Reagents and Kits for the Critical Care Medicine Department (CCMD)

Product Service Code:

6505 NAICS Code:

325414 Place of Performance:

Bethesda, MD 20892 USA POTS: 24-009410 Description This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to Biolegend, Inc. located in San Diego, CA 92121 on a sole source basis for the procurement reagents and kits for the Critical Care Medicine Department (CCMD).

Description/Part #/ Qty TotalSeq™-C Human Universal Cocktail, V1.0/399905/4 The Critical Care Medicine Department is studying the natural history of lung injury and inflammation post COVID19 infection to assess the mechanisms of the injury and the potential treatment options. The TotalSeq™-C Human Universal Cocktail 5T, is used for single cell sequencing in 10X Genomics equipment currently located in CCMD.

Biolegend Inc., is the sole manufacturer and trademark holder of the proprietary antibody TotalSeq™-C Human Universal Cocktail 5T.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.

Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. The total dollar value of this requirement shall not exceed the Simplified Acquisition Threshold (SAT), $250,.000.00. Interested parties may submit capability statements in response to this posting by the closing date for review.

The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Shasheshe Goolsby, Lead Contract Specialist, shasheshe.goolsby@nih.gov by June 26, 6:30AM EST.

Please send your capability statements ONLY. This IS NOT a request for proposal.